RABBITT ANTISERUM TO HUMAN C3C

Complement C3, Antigen, Antiserum, Control

DAKO CORP.

The following data is part of a premarket notification filed by Dako Corp. with the FDA for Rabbitt Antiserum To Human C3c.

Pre-market Notification Details

Device IDK831905
510k NumberK831905
Device Name:RABBITT ANTISERUM TO HUMAN C3C
ClassificationComplement C3, Antigen, Antiserum, Control
Applicant DAKO CORP. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeCZW  
CFR Regulation Number866.5240 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1983-06-14
Decision Date1983-07-18

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05700572002482 K831905 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.